Andreas Schönau

Retrospective Analysis of Topoisomerase IIa Amplifications and Deletions As Predictive Markers in Primary Breast Cancer Patients Randomly Assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group

Ann Knoop, Helle Knudsen, Eva Balslev et al. · Journal of Clinical Oncology · 2005 · 323 citations · Full text

Medicine, Oncology, Pharmacology +17

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

Karen Ege Olsen, Helle Knudsen, Birgitte Rasmussen et al. · Acta Oncologica · 2004 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +15

Mapping the Dimensions of Agency

Andreas Schönau, Ishan Dasgupta, Timothy Brown et al. · AJOB Neuroscience · 2021 · 36 citations · Full text

Engineering, Neuroscience, Psychology +17

Aberrations of <i>ERBB2</i> and <i>TOP2A</i> genes in breast cancer

Kirsten Vang Nielsen, Sven Müller, Susanne Möller et al. · Molecular Oncology · 2009 · 34 citations · Full text

Medicine, Genetics, Oncology +14

Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization

Jens Mollerup, Ulla Henriksen, Sven Müller et al. · BMC Clinical Pathology · 2012 · 27 citations · Full text

Medicine, Molecular Biology, Oncology +15